tiprankstipranks
Insight Molecular Diagnostics (IMDX)
NASDAQ:IMDX
US Market
IMDX
Insight Molecular Diagnostics
RESEARCH TOOLSreports

Insight Molecular Diagnostics (IMDX) Stock News & Sentiment

430 Followers
OncoCyte Earnings Call: GraftAssureDx Drives Pivot
Premium
Company Announcements
OncoCyte Earnings Call: GraftAssureDx Drives Pivot
6d ago
IMDX
Buy Rating on IMDX Driven by Strong GraftAssure Traction, Upcoming FDA Catalyst, and Solid Balance Sheet
Premium
Ratings
Buy Rating on IMDX Driven by Strong GraftAssure Traction, Upcoming FDA Catalyst, and Solid Balance Sheet
14d ago
IMDX
OCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
OCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
17d ago
IMDX
Insight Molecular Diagnostics: GraftAssureIQ Validation and Hospital Adoption Set Up 2026 as a Growth Inflection Year
Premium
Ratings
Insight Molecular Diagnostics: GraftAssureIQ Validation and Hospital Adoption Set Up 2026 as a Growth Inflection Year
1M ago
IMDX
Insight Molecular Diagnostics Signs Quest Specimen Collection Agreement
Premium
Company Announcements
Insight Molecular Diagnostics Signs Quest Specimen Collection Agreement
1M ago
8K
IMDX
Insight Molecular Diagnostics Raises Capital to Advance Transplant R&D
Premium
Company Announcements
Insight Molecular Diagnostics Raises Capital to Advance Transplant R&D
2M ago
8K
IMDX
Insight Molecular Diagnostics Provides Updated Investor Presentation Materials
Premium
Company Announcements
Insight Molecular Diagnostics Provides Updated Investor Presentation Materials
2M ago
8K
IMDX
More IMDX News >

IMDX News on the Web

OncoCyte Earnings Call: GraftAssureDx Drives Pivot
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (PVLA), Insight Molecular Diagnostics (IMDX) and Delcath Systems (DCTH)
TipRanks News
Neutral
Q4 2025 Insight Molecular Diagnostics Inc Earnings Call Transcript
GuruFocus News
Neutral
Analysts Are Bullish on Top Healthcare Stocks: Insight Molecular Diagnostics (IMDX), Tango Therapeutics (TNGX)
TipRanks News
Bullish
Buy Rating on IMDX Driven by Strong GraftAssure Traction, Upcoming FDA Catalyst, and Solid Balance Sheet
TipRanks News
Bullish
Insight Molecular Diagnostics submits GraftAssureDx for FDA review
TipRanks News
Bullish
Insight Molecular Diagnostics reports Q4 EPS (27c) vs. (28c) last year
TipRanks News
Bearish
OCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
IMDX
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.5 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMDX’s Media Buzz Sentiment?
1 articles about IMDX were published this week. In an average week, 2.5 articles are published.
    What is IMDX’s weekly average amount of articles?
    In an average week, 2.5 articles about IMDX are published.
      What is IMDX’s News Sentiment?
      50% of articles about IMDX were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        AORTArtivion
        OWLTOwlet
        STAAStaar Surgical
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week